AZTherapies IPO

www.aztherapies.com

AZTherapies is a biopharmaceutical company developing novel small molecules and biologic therapies that aim to fundamentally change neurodegenerative disease progression, extending normal cognition and function and improving quality of life in the aging population.

Founded2011
Total Funding to Date$121.38MM
Register for Details

For more details on financing and valuation for AZTherapies, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

AZTherapies Ticker Symbol

AZTherapies does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

AZTherapies Stock Price

The stock price for AZTherapies will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

AZTherapies Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
8/28/2020 Series C-1 $35MM raised $XXX.XX $XXX.XX
10/7/2019 Series C $37.5MM raised $XXX.XX $XXX.XX
6/18/2018 Series B $18.98MM raised $XXX.XX $XXX.XX
11/20/2015 Series A and A-2 $22.96MM raised $XXX.XX $XXX.XX
12/22/2014 Series A-1 $6.93MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like AZTherapies in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector